Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2012 2
2013 2
2014 2
2015 1
2017 1
2020 1
2021 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Myeloid Sarcoma: Presentation, Diagnosis, and Treatment.
Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Almond LM, et al. Clin Lymphoma Myeloma Leuk. 2017 May;17(5):263-267. doi: 10.1016/j.clml.2017.02.027. Epub 2017 Mar 7. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28342811 Review.
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare condition, most often associated with acute myeloid leukemia (AML), although in some rare cases it may present in nonleukemic patients. ...
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare condition, most often associated with …
Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML.
Falini B, Dillon R. Falini B, et al. Blood Cancer Discov. 2024 Jan 8;5(1):8-20. doi: 10.1158/2643-3230.BCD-23-0144. Blood Cancer Discov. 2024. PMID: 37917833 Review.
NPM1-mutated acute myeloid leukemia (AML) represents the largest molecular subgroup of adult AML. NPM1-mutated AML is recognizable by molecular techniques and immunohistochemistry, which, when combined, can solve difficult diagnostic problems (including identification of …
NPM1-mutated acute myeloid leukemia (AML) represents the largest molecular subgroup of adult AML. NPM1-mutated AML is recognizable by …
Clinical characteristics, treatment options, and prognosis of myeloid sarcoma: analysis using the SEER database.
Liang J, Yang L, Yang B, Tian Y, Ren J, Yang L. Liang J, et al. Hematology. 2023 Dec;28(1):2247898. doi: 10.1080/16078454.2023.2247898. Hematology. 2023. PMID: 37594298
BACKGROUND: Myeloid sarcoma (MS) is a very rare hematologic disorder. This study analyzes the early treatment options for patients with different types of MS and explores the prognostic factors of MS. ...RESULTS: Data were collected from 472 patients: 244 patients w …
BACKGROUND: Myeloid sarcoma (MS) is a very rare hematologic disorder. This study analyzes the early treatment options for pati …
Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 2.
Chokoeva AA, Tchernev G, Cardoso JC, Patterson JW, Dechev I, Valkanov S, Zanardelli M, Lotti T, Wollina U. Chokoeva AA, et al. Int J Immunopathol Pharmacol. 2015 Jun;28(2):178-86. doi: 10.1177/0394632015575977. Epub 2015 Mar 26. Int J Immunopathol Pharmacol. 2015. PMID: 25816393 Free article. Review.
In Part 1 of this paper, we presented the most common forms of sarcoma of the vulva: leiomyosarcoma, epithelioid sarcoma, malignant rhabdoid tumor, and rhabdomyosarcoma. The second part of this review will focus mainly on the rarest variants of vulvar sarcoma …
In Part 1 of this paper, we presented the most common forms of sarcoma of the vulva: leiomyosarcoma, epithelioid sarcoma, mali …
Treatment Outcomes of Intracranial Myeloid Sarcomas: A Meta-Analysis.
Lee D, Omofoye OA, Nuño MA, Riestenberg RA, Shahlaie K. Lee D, et al. World Neurosurg. 2021 Apr;148:29-37. doi: 10.1016/j.wneu.2021.01.004. Epub 2021 Jan 11. World Neurosurg. 2021. PMID: 33444829 Review.
OBJECTIVE: Intracranial myeloid sarcomas (IMS) are rare central nervous system manifestations of malignant hematopoietic neoplasms of myeloid origin such as acute myeloid leukemia and chronic myeloid leukemia. ...RESULTS: The mean age at diagnosis was …
OBJECTIVE: Intracranial myeloid sarcomas (IMS) are rare central nervous system manifestations of malignant hematopoietic neoplasms of …
Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis.
Audouin J, Comperat E, Le Tourneau A, Camilleri-Broët S, Adida C, Molina T, Diebold J. Audouin J, et al. Int J Surg Pathol. 2003 Oct;11(4):271-82. doi: 10.1177/106689690301100404. Int J Surg Pathol. 2003. PMID: 14615822 Review.
Extramedullary accumulation of myeloblasts or immature myeloid cells form tumors called myeloid sarcoma in the WHO classification. ...The diagnosis is missed in about 50% of cases when immunohistochemistry is not used. Patients with myeloid sarcomas sh …
Extramedullary accumulation of myeloblasts or immature myeloid cells form tumors called myeloid sarcoma in the WHO clas …
Is there a "gold" standard treatment for patients with isolated myeloid sarcoma?
Antic D, Elezovic I, Milic N, Suvajdzic N, Vidovic A, Perunicic M, Djunic I, Mitrovic M, Tomin D. Antic D, et al. Biomed Pharmacother. 2013 Feb;67(1):72-7. doi: 10.1016/j.biopha.2012.10.014. Epub 2012 Nov 19. Biomed Pharmacother. 2013. PMID: 23218987
Myeloid sarcoma is a very rare condition, and few cases have been reported. ...While prospective evaluations are needed, chemotherapy with allogenic hematopoietic stem cell transplantation should be considered as the optimal therapy for isolated myeloid …
Myeloid sarcoma is a very rare condition, and few cases have been reported. ...While prospective evaluations are needed, chemo …
Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution.
Breccia M, Mandelli F, Petti MC, D'Andrea M, Pescarmona E, Pileri SA, Carmosino I, Russo E, De Fabritiis P, Alimena G. Breccia M, et al. Leuk Res. 2004 Nov;28(11):1165-9. doi: 10.1016/j.leukres.2004.01.022. Leuk Res. 2004. PMID: 15380340 Review.
The aim of this study was to describe the presenting features, the frequency and outcome of myeloid sarcoma (MS) diagnosed in our Institution from January 1995 to December 2000. Twelve MS were seen and the frequency account for only 2% of all acute myeloid le …
The aim of this study was to describe the presenting features, the frequency and outcome of myeloid sarcoma (MS) diagnosed in …
14 results